AI-ML-enabled-real-world-evidenceRWE-analytics-1

    AI/ML-enabled real-world evidence analytics

    Augment value for pharma and medical devices by analyzing real-world evidence (RWE) across the product life cycle.

    Real-world evidence

    RWE rises to support clinical inferences on treatment efficacies. The information from electronic health records (EHR) and electronic medical records (EMR) along with other patient treatment records is compelling to guide companies, physicians, and the managed care ecosystem to deliver truly benefitting patient outcomes. Razor-sharp data and analytics capabilities are crucial for harvesting real-world data (RWD) and delivering evidence-based assessments across the healthcare value continuum.

    Axtria’s experience with RWD processing and management, along with its AI/ML RWE models help healthcare stakeholders generate and demonstrate value and meet growing evidence generation requirements.

    AI-driven solution applications

    AI-driven-solution-applications-icon1-1

    AI/ML models to quantify the magnitude of misdiagnosed patients for targeted intervention.

    AI-driven-solution-applications-icon2-1

    New product insights into market access through patient sub-population model.

    AI-driven-solution-applications-icon3-1

    Identifying “biologic-ready” patients for better insights into the overall disease burden.

    Drivers for evidence-based demonstrations across the product life cycle

    Pre-launch
    Pre-launch-icon
    • Unmet needs and disease burden
    • Patient recruitment
    • Understand the standard of care
    • Clinical trial design
    Launch and scale
    Launch-and-Scale-icon
    • Patient safety
    • Product comparative effectiveness
    • Patient adherence
    • Prescribing patterns
    • Differentiation in sub-populations
    • Long-term clinical outcomes
    • Target population implications
    Loss-of-exclusivity (LOE)
    Loss-of-exclusivity-icon
    • Effects of switching on outcomes
    • Usage differences
    • Differentiate with or vs. protected formulation
    • For payers to deliver cost-effective care coverage and value for patients’ money.
    • For providers to identify better ways to manage patient health.
    • For life sciences organizations to make better decisions related to pre-launch, market access, and commercialization.

    Axtria’s RWE/HEOR solutions span across the healthcare value spectrum

    RWD Expertise

    RWD-EXPERTISE-Icon1

    Patient claims

    RWD-EXPERTISE-Icon2

    EHR/EMR data

    RWD-EXPERTISE-Icon3

    Lab results

    RWD-EXPERTISE-Icon4

    Patient registries

    RWD-EXPERTISE-Icon5

    Adverse event reporting

    RWD-EXPERTISE-Icon6

    Patient-powered research networks (PPRN)

    RWE/HEOR Applications Across Domains

    RWE-HEOR-APPLICATIONS-Icon1

    Study design

    RWE-HEOR-APPLICATIONS-Icon2

    Epidemiology analysis

    RWE-HEOR-APPLICATIONS-Icon3

    Real-world comparative analysis

    RWE-HEOR-APPLICATIONS-Icon4

    Patient compliance and persistence

    RWE-HEOR-APPLICATIONS-Icon5

    Market access and reimbursement strategy

    RWE-HEOR-APPLICATIONS-Icon6

    Biomarker analysis

    RWE-HEOR-APPLICATIONS-Icon7

    Burden of disease analysis

    RWE-HEOR-APPLICATIONS-Icon8

    Drug utilization and patient profiling

    RWE-HEOR-APPLICATIONS-Icon9

    Publication and HTA submission support

    RWE-HEOR-APPLICATIONS-Icon10

    Budget impact analysis

    Axtria research hub

    Blog

    RWE in Clinical Trials – Market Trends and Use Cases

    Report

    Risk Of Venous Thromboembolism And Major Bleeding In Patients With Acute Medical Illness Receiving Thromboprophylaxis With Enoxaparin

    White Paper

    Real-World Data-Based Simulations: Generating Medical Evidence From Clinical Trial And Real-World Data